NICE has recommended cemiplimab for eligible adults with recurrent or [...]

Inaqovi in combination with venetoclax has received an amended European [...]

Neurological pathway illustration showing myelin sheath repair; MRI brain imaging; [...]

ViiV Healthcare has secured FDA Priority Review for its application [...]

The UK health watchdog NICE has recommended NHS reimbursement of [...]

Atsena Therapeutics has dosed the first patient in the Phase [...]

The European Commission has approved BRAFTOVI in combination with cetuximab [...]

African health leaders have launched the Imara Sickle Cell Framework [...]

F2G and Shionogi have reported that oral olorofim met the [...]

Ananda Pharma has reported positive results from its Phase 1 [...]